Structures by: Hamzah N.
Total: 5
4,4,6-Trimethyl-1-phenyl-3,4-dihydropyrimidine-2(1H)-thione
C13H16N2S
Acta Crystallographica Section E (2005) 61, 1 o55-o57
a=10.0407(16)Å b=17.007(3)Å c=30.197(5)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C18H18N2O3
Acta Crystallographica Section E (2010) 66, 7 o1824-o1825
a=8.997(2)Å b=12.988(3)Å c=15.030(3)Å
α=103.764(6)° β=107.202(6)° γ=102.929(6)°
Ethyl 1-(2-hydroxyethyl)-2-propyl-1<i>H</i>-benzimidazole-5-carboxylate
C15H20N2O3
Acta Crystallographica Section E (2011) 67, 10 o2704
a=8.5081(3)Å b=8.5573(3)Å c=10.0117(4)Å
α=94.671(3)° β=106.903(2)° γ=98.334(3)°
Ethyl 1-(2-hydroxyethyl)-2-[2-(methylsulfanyl)ethyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C15H20N2O3S
Acta Crystallographica Section E (2012) 68, 1 o197-o198
a=8.39090(10)Å b=8.8277(2)Å c=11.5025(2)Å
α=110.2180(10)° β=102.5290(10)° γ=99.1010(10)°
2-<i>sec</i>-Butyl-1-(2-hydroxyethyl)-1<i>H</i>-benzimidazole-5-carboxylic acid
C14H18N2O3
Acta Crystallographica Section E (2012) 68, 7 o1995
a=8.9427(2)Å b=8.2067(2)Å c=18.3536(3)Å
α=90.00° β=94.4150(10)° γ=90.00°